These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6797511)

  • 1. Brittle diabetes: long-term control with a portable, continuous, intravenous insulin infusion system.
    Bayliss J
    Br Med J (Clin Res Ed); 1981 Nov; 283(6301):1207-9. PubMed ID: 6797511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of severely brittle diabetes by continuous subcutaneous and intramuscular insulin infusions: evidence for a defect in subcutaneous insulin absorption.
    Pickup JC; Home PD; Bilous RW; Keen H; Alberti KG
    Br Med J (Clin Res Ed); 1981 Jan; 282(6261):347-50. PubMed ID: 6780019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous subcutaneous insulin infusion:good blood glucose control for up to 4 days.
    Pickup JC; Keen H; Parsons JA; Alberti KG
    Diabetologia; 1979 Jun; 16(6):385-9. PubMed ID: 467848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term ambulatory peritoneal insulin infusion of brittle diabetes with portable pumps: comparison with intravenous and subcutaneous routes.
    Selam JL; Slingeneyer A; Hedon B; Mares P; Beraud JJ; Mirouze J
    Diabetes Care; 1983; 6(2):105-11. PubMed ID: 6406198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term continuous intraperitoneal insulin treatment in brittle diabetes.
    Pozza G; Spotti D; Micossi P; Cristallo M; Melandri M; Piatti PM; Monti LD; Pontiroli AE
    Br Med J (Clin Res Ed); 1983 Jan; 286(6361):255-6. PubMed ID: 6402060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia.
    Pickup JC; Keen H; Parsons JA; Alberti KG
    Br Med J; 1978 Jan; 1(6107):204-7. PubMed ID: 340000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term, ambulatory, subcutaneous insulin infusion versus multiple daily injections in brittle diabetic patients.
    Barbosa J; Menth L; Eaton J; Sutherland D; Freier EF; Najarian J
    Diabetes Care; 1981; 4(2):269-74. PubMed ID: 7011745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term continuous subcutaneous insulin infusion in diabetics at home.
    Pickup JC; White MC; Keen H; Parsons JA; Alberti KG
    Lancet; 1979 Oct; 2(8148):870-3. PubMed ID: 90966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a portable insulin infusion pump for outpatient management of brittle diabetes.
    Kitabchi AE; Fisher JN; Burghen GA; Gaylord MS; Blank NM
    Diabetes Care; 1979; 2(5):421-4. PubMed ID: 510142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diabetes therapy with continuous insulin infusion by a portable pump: metabolic effects of short-term treatment and long-term results in problem patients].
    Schernthaner G; Graninger W; Kwasny W; Prager R; Otto C
    Acta Med Austriaca; 1982; 9(5-6):205-13. PubMed ID: 6762034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Insulin therapy by subcutaneous infusion using a portable pump. A simple method to stabilize brittle diabetics (author's transl)].
    Berger W; Schwarz U; Kaegi E; Keller U; Viollier E
    Schweiz Rundsch Med Prax; 1979 Dec; 68(49):1620-9. PubMed ID: 397488
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term continuous intravenous insulin therapy with a portable insulin dosage-regulating apparatus.
    Irsigler K; Kritz H
    Diabetes; 1979 Mar; 28(3):196-203. PubMed ID: 446904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lower rate of initial failures and reduced occurrence of adverse events with a new catheter model for continuous subcutaneous insulin infusion: prospective, two-period, observational, multicenter study.
    Renard E; Guerci B; Leguerrier AM; Boizel R;
    Diabetes Technol Ther; 2010 Oct; 12(10):769-73. PubMed ID: 20809682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes responsive to intravenous but not subcutaneous insulin: effectiveness of aprotinin.
    Freidenberg GR; White N; Cataland S; O'Dorisio TM; Sotos JF; Santiago JV
    N Engl J Med; 1981 Aug; 305(7):363-8. PubMed ID: 7019707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical application of pre-programmed insulin infusion: continuous subcutaneous insulin therapy with a portable infusion system.
    Pickup JC; Viberti GC; Keen H; Parsons JA; Alberti KG
    Horm Metab Res Suppl; 1979; (8):202-4. PubMed ID: 395081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of diabetes mellitus by devices.
    Soeldner JS
    Am J Med; 1981 Jan; 70(1):183-94. PubMed ID: 7006391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous subcutaneous insulin infusion: improved blood-glucose and intermediary-metabolite control in diabetics.
    Pickup JC; Keen H; Parsons JA; Alberti KG; Rowe AS
    Lancet; 1979 Jun; 1(8129):1255-7. PubMed ID: 87724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous intravenous insulin infusion in the management of brittle diabetes: etiologic and therapeutic implications.
    Williams G; Pickup JC; Keen H
    Diabetes Care; 1985; 8(1):21-7. PubMed ID: 3971843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outpatient treatment of juvenile-onset diabetes with a preprogrammed portable subcutaneous insulin infusion system.
    Tamborlane WV; Sherwin RS; Genel M; Felig P
    Am J Med; 1980 Feb; 68(2):190-6. PubMed ID: 6986766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A portable infusion pump, programmable with 16 rates.
    Bojsen J; Kølendorf K; Haslev F; Jørgensen K
    Biotelem Patient Monit; 1978; 5(3):123-33. PubMed ID: 754819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.